<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1413-8670</journal-id>
<journal-title><![CDATA[Brazilian Journal of Infectious Diseases]]></journal-title>
<abbrev-journal-title><![CDATA[Braz J Infect Dis]]></abbrev-journal-title>
<issn>1413-8670</issn>
<publisher>
<publisher-name><![CDATA[Brazilian Society of Infectious Diseases]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1413-86702004000200007</article-id>
<article-id pub-id-type="doi">10.1590/S1413-86702004000200007</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Risk factors for Toxoplasma gondii infection in women of childbearing age]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Avelino]]></surname>
<given-names><![CDATA[Mariza Martins]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Campos Júnior]]></surname>
<given-names><![CDATA[Dioclécio]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Parada]]></surname>
<given-names><![CDATA[Josetti Barbosa de]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Castro]]></surname>
<given-names><![CDATA[Ana Maria de]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,University of Brasília Department of Pediatrics of the Health Science School ]]></institution>
<addr-line><![CDATA[Brasília DF]]></addr-line>
<country>Brazil</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2004</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2004</year>
</pub-date>
<volume>8</volume>
<numero>2</numero>
<fpage>164</fpage>
<lpage>174</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.br/scielo.php?script=sci_arttext&amp;pid=S1413-86702004000200007&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><self-uri xlink:href="http://www.scielo.br/scielo.php?script=sci_abstract&amp;pid=S1413-86702004000200007&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><self-uri xlink:href="http://www.scielo.br/scielo.php?script=sci_pdf&amp;pid=S1413-86702004000200007&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[OBJECTIVES: Determine the risk factors involved in toxoplasmosis transmission and determine whether pregnancy is a risk factor for toxoplasmosis infection. STUDY DESIGN: Cross-sectional study carried out on 2,242 women at childbearing age. An indirect immunofluorescence reaction was used to identify immunity to Toxoplasma gondii. Previous gestations were also analyzed as a possible risk factor. The results were analyzed by chi2 and OR tests, and by variance analysis. The sample was statistically balanced according to social-economic risk factors. RESULTS: Previously pregnant women were 1.74 times more frequently infected with toxoplasmosis, regardless of environmental conditions. Pregnant women living under unfavorable environmental conditions had an approximately two times increased risk of being infected for each risk factor (contact with host animals, presence of vehicles of oocyst transmission). Previous pregnancy was the risk factor that had the strongest influence on acquiring toxoplasmosis (variance analysis and statistical balancing). DISCUSSION: The prevalence of this zoonosis is high in Goiânia-GO, Brazil (65.8%). Inadequate environmental sanitation was not significantly correlated with toxoplasmosis infection, except when associated with previous pregnancy, showing that the fundamental cause for infection is not environmental. CONCLUSION: The finding that pregnancy makes women more vulnerable to this protozoan, makes it important to implement prophylactic control of at-risk pregnant women.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Toxoplasmosis in pregnancy]]></kwd>
<kwd lng="en"><![CDATA[risk factor]]></kwd>
<kwd lng="en"><![CDATA[host animals]]></kwd>
<kwd lng="en"><![CDATA[means of transmission]]></kwd>
<kwd lng="en"><![CDATA[contaminant elements]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <p align="right"><font size="2" face="Verdana"><b>ORIGINAL PAPERS</b></font></p>     <p>&nbsp;</p>     <p><font size="4" face="Verdana"><B><a name="tx"></a>Risk factors    for <I>Toxoplasma gondii</I> infection in    women of childbearing age </b></font></p>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><font size="2" face="Verdana"><B>Mariza Martins Avelino; Diocl&eacute;cio Campos    J&uacute;nior; Josetti Barbosa de Parada; Ana Maria de Castro</b> </font></p>     <p><font size="2" face="Verdana">Department of Pediatrics of the Health Science    School, University of Bras&iacute;lia, Bras&iacute;lia, DF, Brazil </font></p>     <p><font size="2" face="Verdana"><a href="#end">Correspondence</a></font></p>     <p>&nbsp;</p>     <p>&nbsp;</p> <hr size="1" noshade>     ]]></body>
<body><![CDATA[<p><font size="2" face="Verdana"><b>ABSTRACT</b></font></p>     <p><font size="2" face="Verdana"><b>OBJECTIVES:</b> Determine the risk factors    involved in toxoplasmosis transmission and determine whether pregnancy is a    risk factor for toxoplasmosis infection.     <br>   <b>STUDY DESIGN:</b> Cross-sectional study carried out on 2,242 women at childbearing    age. An indirect immunofluorescence reaction was used to identify immunity to    <I>Toxoplasma gondii</I>. Previous gestations were also analyzed as a possible    risk factor. The results were analyzed by <font face="Symbol">c</font><sup>2</sup>    and OR tests, and by variance analysis. The sample was statistically balanced    according to social-economic risk factors.     <br>   <b>RESULTS:</b> Previously pregnant women were 1.74 times more frequently    infected with toxoplasmosis, regardless of environmental conditions. Pregnant    women living under unfavorable environmental conditions had an approximately    two times increased risk of being infected for each risk factor (contact with    host animals, presence of vehicles of oocyst transmission). Previous pregnancy    was the risk factor that had the strongest influence on acquiring toxoplasmosis    (variance analysis and statistical balancing).    <br>   <b>DISCUSSION:</b> The prevalence of this zoonosis is high in Goi&acirc;nia-GO,    Brazil (65.8%). Inadequate environmental sanitation was not significantly correlated    with toxoplasmosis infection, except when associated with previous pregnancy,    showing that the fundamental cause for infection is not environmental.     <br>   <b>CONCLUSION:</b> The finding that pregnancy makes women more vulnerable    to this protozoan, makes it important to implement prophylactic control of at-risk    pregnant women. </font></p>     <p><font size="2" face="Verdana"><b>Key words:</b> Toxoplasmosis in pregnancy;    risk factor; host animals; means of transmission; contaminant elements.</font></p> <hr size="1" noshade>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><font size="2" face="Verdana">Toxoplasmosis is important due to the possibility    of transplacental transmission, harming the fetus. The rate of risk for pregnancy    depends on infection prevalence among women at childbearing age, the types of    meat that they eat, the degree of contact between vulnerable pregnant women    and protozoan transmission sources, and the stage of gestation when transmission    occurs; the earlier in gestation that transmission occurs, the greater the severity    of sequelae in the fetus or newborn &#91;1-9&#93;. </font></p>     ]]></body>
<body><![CDATA[<p><font size="2" face="Verdana"> Animals infected with <I>Toxoplasma gondii </I>transmit    infective cysts to humans through ingestion of raw or undercooked meat. Oral    transmission can also occur by ingestion of food or water contaminated with    oocysts, which are eliminated in cat feces &#91;10,11&#93;. </font></p>     <p><font size="2" face="Verdana"> In different regions of the world, various types    of factors have been implicated in toxoplasmosis transmission, however in the    United States and France the ingestion of meat (beef, mutton or pork) containing    parasite cysts is the most common source of human infection &#91;2&#93;. </font></p>     <p><font size="2" face="Verdana"> Oocysts can be carried or ingested by animals,    such as invertebrate coprophages (flies and cockroaches), which can serve as    a source of contamination of water and food &#91;10&#93;, or of birds and rodents, which    then infect cats &#91;10,11&#93;. <I>Toxoplasma gondii</I> has also been isolated from    chicken eggs, but this is not considered an important route of oral transmission    &#91;2&#93;. </font></p>     <p><font size="2" face="Verdana"> Unpasteurized goat's milk can also be a source    of oral transmission of toxoplasmosis &#91;2&#93;. This epidemiological data is important    in regions where this animal replaces cattle in the dairy industry (Northeast    of Brazil) and for children who are allergic to cow's milk. </font></p>     <p><font size="2" face="Verdana"> All the aforementioned sources of transmission    are responsible for the worldwide distribution of this infection (40%-60%) and    for the highly variable prevalence rates in several locations &#91;12-20&#93;. The incidence    of infection depends on the immunological state of the population. It also depends    on favorable environmental conditions, such as hot weather, for the survival    of the oocysts, which are eliminated in cat feces &#91;1,2,4,5&#93;. </font></p>     <p><font size="2" face="Verdana"> The incidence of infection increases with age,    and several studies have shown higher prevalence among women at childbearing    age, although children are more exposed to the sources of transmission of this    parasite &#91;2&#93;. This fact is intriguing and suggests that key factors that influence    the vulnerability of the human organism to the parasite still need to be studied.    Some studies have given conflicting results. A study in Australia could not    relate exposure of women presenting seroconversion to any known risk factors    &#91;21&#93;. In the Netherlands, there was an inexplicable rise of infection rate at    the end of pregnancy, despite prophylactic measures &#91;22&#93;. Perhaps this was due    to immunological alterations that occur in pregnant women, which can provoke    immune suppression &#91;23-27&#93;. </font></p>     <p><font size="2" face="Verdana"> During pregnancy, especially at the end, there    are alterations in the mother's T-lymphocyte sub-populations, with CD<SUB>4</SUB>    lymphocytes decreasing and CD<SUB>8</SUB> lymphocytes increasing; the NK (natural    killer) cells also have decreased immune functions of neutrophils, monocytes,    and macrophages &#91;24,25,27&#93;. The phagocytic function and the chemotaxis of polymorphonuclear    neutrophils are depleted in women between the 30th and 34th weeks of gestation,    which would explain the higher vulnerability to the invasion of <I>T. gondii</I>    during the third trimester of pregnancy &#91;27&#93;. Although there are many studies    about risk factors to acquire toxoplasmosis and its effects on pregnancy, no    studies on the risk of pregnancy itself to acquire this infection have been    made. </font></p>     <p><font size="2" face="Verdana"> We examined the risk factors associated with    infection by <I>T. gondii</I> and whether pregnancy can be considered a risk    factor for acquiring this protozoan infection. </font></p>     <p>&nbsp;</p>     <p><font size="3" face="Verdana"><B>Material and Methods</B> </font></p>     ]]></body>
<body><![CDATA[<p><font size="2" face="Verdana"> This study was carried out from 1997 to 1999,    in Goi&acirc;nia-GO, Brazil, a state capital in the Midwestern region of Brazil.    A cross-sectional community-based or nested study (in a longitudinal study)    was made of acute toxoplasmosis in women at childbearing age (12 to 49 years    old). </font></p>     <p><font size="2" face="Verdana"> Women at childbearing age were identified via    parental clinics, birth control groups, communitarian work groups, religious    congregations, or in public elementary and high schools, and they were invited    to meetings. After explaining the program, informed consent was obtained from    volunteers and blood samples were collected. Serological screening showed that    65.8% of the women were seropositive.Trained interviewers interviewed 2,563    of these women. </font></p>     <p><font size="2" face="Verdana"> Women negative for toxoplasma-specific IgG,    or with levels lower than 1/20, and negative for toxoplasma -pecific IgM, or    with levels lower than 1/5, based on an indirect immunofluorescent antibody    test (IFAT), were considered at risk. The indirect immunofluorescent antibody    test was processed in the Department of Parasitology of the Institute of Tropical    Pathology and Public Health of the Federal University of Goi&aacute;s (IPTESP-UFG).    The immune reaction detected IgG and IgM antibodies specific for <I>T. gondii</I>,    labeled with fluorescein, using the Biolab (France) conjugate, the G and M Fluoline,    and the RH strain of <I>T. gondii.</I> The finding of IgM specific for toxoplasma    was confirmed by removing the rheumatoid factor from positive serum, using reagents    manufactured by Bio Merrier (France). Quality control was carried out by the    Immunology Departments of IPTESP and the Hospital das Cl&iacute;nicas (Federal    University of Goi&aacute;s), using the immunoenzyme test (ELISA), produced by    Clark (USA) for IgM and Salk (Brazil) for IgG, both prepared according to the    manufacturers' instructions. </font></p>     <p><font size="2" face="Verdana"> The results of the laboratory exams indicated    seronegative and seropositive women depending on whether IgG levels were higher    than 1/20, since this was the initial level. On the other hand, being pregnant    or not at the moment of the exam did not influence the presence or absence of    immunity at the time of diagnostic screening, and the women were then subdivided    into two more groups: those who had not been previously pregnant (nulliparous    or primiparous) and those with previous pregnancies. </font></p>     <p><font size="2" face="Verdana"> Essential criteria for inclusion in the study    were: a) interview to collect information about risk indicators of toxoplasmosis    infection; b) absence of IgM antibodies specific for <I>T. gondii;</I> and c)    medical records with sufficient and clear information about age and previous    pregnancies. </font></p>     <p><font size="2" face="Verdana"> Criteria for exclusion were the following: a)    presence of IgG antibodies at levels <U>&gt;</U>1/4,096, with or without IgM;    b) IgG level <U>&lt;</U> 1/40 but with presence of IgM; c) seronegativity detected    by IFAT but not confirmed by ELISA; and d) questionnaires that did not contain    essential information to the analysis (prior gestations and age). </font></p>     <p><font size="2" face="Verdana"> Among the initial group of women, who were submitted    to the above-mentioned criteria, 55 were suspected to have acute toxoplasmosis,    105 presented false-negative reactions and for 161 there was a lack of basic    information in the medical records, and therefore they were excluded. </font></p>     <p><font size="2" face="Verdana"> The following were analyzed as possible risk    factors for toxoplasmosis: a) deficiencies in environmental sanitation (water    and sewage treatment, garbage collection); b) presence of host animals in the    house (cats and dogs); c) contact with vehicles of oocyst transmission (flies,    cockroaches and rats); d) consumption of potentially contaminated food (raw    or undercooked meat, raw or undercooked eggs, raw or undercooked, inappropriately    washed vegetables, and unpasteurized goat's milk); e) pica, geophagia, or inadequate    soil handling; g) low level of formal education (<U>&lt;</U> four years); h)    low family income (<U>&lt;</U> two minimum wages); i) previous pregnancy. </font></p>     <p><font size="2" face="Verdana"> Different known risk factors to acquire toxoplasmosis    were compared in two groups: women who had already had toxoplasmosis (infected)    and those who had never had the infection (non-infected). In both groups, it    was investigated whether a previous pregnancy resulted in higher risk for acquiring    the disease. </font></p>     <p><font size="2" face="Verdana"> The women were divided into five year age groups,    except for the extremes: adolescents (&lt; 20 years old) and older women (35    years or more). We analyzed the different risk factors involved in toxoplasmosis    infection and the possible association between these factors with previous pregnancy.    </font></p>     ]]></body>
<body><![CDATA[<p><font size="2" face="Verdana"> The behavior of these variables was analyzed    with the c<sup>2</sup> test, using the presence of infection as the dependent variable.    Data were analyzed using Excel version 97 (Microsoft, Brasil), EPI-INFO (version    6.0, CDC, USA) and SPSS (version 93, USA). The significance level at 5% and    the limits of reliability at 95% were used. The Odds Ratio (OR) for the risk    factors to which the women were exposed was calculated for each risk factor    and for age group. </font></p>     <p><font size="2" face="Verdana"> The data were also submitted to variance analysis    and the sample was statistically balanced according to social-economic risk    factors, which were not homogeneous. Inadequate environmental sanitation and    low levels of education, which were prevalent, but not homogeneous, were considered    social risks in our study. In order to balance the sample and make it homogeneous,    123 women were excluded: three were illiterate and lived in houses without environmental    sanitation; 15 were in houses without environmental sanitation, but with up    to four years education; 22 lived in houses without environmental sanitation,    but with for more than four years education; nine were in houses with water    and sewage treatment but without garbage collection and with for more than four    years education; and 74 were in houses with environmental sanitation but they    a low level of education. The cuts were made randomly with a raffle. </font></p>     <p>&nbsp;</p>     <p><font size="3" face="Verdana"><B>Results</B> </font></p>     <p><font size="2" face="Verdana"> The sample of 2,242 women at childbearing age    lived in the surroundings of Goi&acirc;nia, GO. The social      organization investigation showed that 61.8% of the women were included in a    stable family context (44.4% married and 17.4% living in concubinage). </font></p>     <p><font size="2" face="Verdana"> According to the social-economic investigation,    41.4% (909/2,195) of the women earned less than two minimum salaries (one minimum    salary was about US$90 at the time of the study) and lived with financial difficulty.    Previous residence in a rural area was found to be a risk factor for acquiring    toxoplasmosis (<font face="Symbol">c</font><sup>2</sup> = 16.7 and p=0.000004).    Living in houses with just a few rooms and in crowded conditions was not a risk    factor for <I>T. gondii</I> infection. </font></p>     <p><font size="2" face="Verdana"> The exposure of this population to vehicles    of oocyst transmission was high: 77.4% of the women were in contact with flies,    79.0% with cockroaches, and 40.7% with rats. </font></p>     <p><font size="2" face="Verdana"> The ingestion of raw or undercooked meat was    a frequent habit in theis population, practiced by 42.1% of the women. </font></p>     <p><font size="2" face="Verdana"> <a href="#tab01">Table 1</a> shows the distribution    of the women studied, divided according to previous occurrence of pregnancy,    among infected (1,148) and non-infected (1,094) individuals. A significant association    was found in this case, with a 1.74 times higher risk of acquiring toxoplasmosis    in previously pregnant women. </font></p>     <p><a name="tab01"></a></p>     ]]></body>
<body><![CDATA[<p>&nbsp;</p>     <p align="center"><img src="/img/revistas/bjid/v8n2/a07tab01.gif"></p>     <p>&nbsp;</p>     <p><font size="2" face="Verdana"> The relationship between low income and presence    of toxoplasmosis in women at childbearing age for different age groups was examined    (<a href="#tab02">Table 2</a>). A significant association was found in this    case; adolescents with low income exhibited a greater risk of acquiring toxoplasmosis.    </font></p>     <p><a name="tab02"></a></p>     <p>&nbsp;</p>     <p align="center"><img src="/img/revistas/bjid/v8n2/a07tab02.gif"></p>     <p>&nbsp;</p>     <p><font size="2" face="Verdana"> The relationship between level of formal education    and occurrence of toxoplasmosis in women at childbearing age for different age    groups was also examined (<a href="#tab03">Table 3</a>). significant association    was demonstrated for women in general, and moreover for women between 20 and    25 years old, who showed risk 3.24 times higher to acquire toxoplasmosis. </font></p>     <p><a name="tab03"></a></p>     ]]></body>
<body><![CDATA[<p>&nbsp;</p>     <p align="center"><img src="/img/revistas/bjid/v8n2/a07tab03.gif"></p>     <p>&nbsp;</p>     <p><font size="2" face="Verdana"> We investigated the relationship between environmental    risk factors and toxoplasmosis (<a href="#tab04">Table 4</a>). A significant    statistical association was with toxoplasmosis only found when women indicated    a previous pregnancy, with an approximately two times higher risk for previously    pregnant, compared to nulliparous women, all of whom had contact with cats,    dogs, flies, cockroaches, rats, and/or inadequate soil handling. </font></p>     <p><a name="tab04"></a></p>     <p>&nbsp;</p>     <p align="center"><img src="/img/revistas/bjid/v8n2/a07tab04.gif"></p>     <p>&nbsp;</p>     <p><font size="2" face="Verdana"> A significant association between toxoplasmosis    infection and lack of water and sewage treatment was only found for adolescents.    The presence of vehicles of oocyst transmission was a significant contributing    factor for acquiring this infection only in those adolescents who reported a    previous pregnancy (<a href="#tab05">Table 5</a>). </font></p>     <p><a name="tab05"></a></p>     ]]></body>
<body><![CDATA[<p>&nbsp;</p>     <p align="center"><img src="/img/revistas/bjid/v8n2/a07tab05.gif"></p>     <p>&nbsp;</p>     <p><font size="2" face="Verdana"> The risk of infection was very high only in    previously pregnant women (<a href="#tab06">Table 6</a>), who were almost twice    as likely to be infected among those who consumed raw or undercooked meat or    eggs, or raw or undercooked, inappropriately washed, vegetables. There was no    significant association of alimentary risk factors with toxoplasmosis in adolescents    (<a href="#tab07">Table 7</a>). </font></p>     <p><a name="tab06"></a></p>     <p>&nbsp;</p>     <p align="center"><img src="/img/revistas/bjid/v8n2/a07tab06.gif"></p>     <p>&nbsp;</p>     <p><a name="tab07"></a></p>     <p>&nbsp;</p>     ]]></body>
<body><![CDATA[<p align="center"><img src="/img/revistas/bjid/v8n2/a07tab07.gif"></p>     <p>&nbsp;</p>     <p><font size="2" face="Verdana"> <a href="#tab08">Table 8</a> shows the relationship    between several risk factors and toxoplasmosis after balancing the sample, which    did not modify the conclusion that pregnancy is a risk factor for infection.    </font></p>     <p><a name="tab08"></a></p>     <p>&nbsp;</p>     <p align="center"><img src="/img/revistas/bjid/v8n2/a07tab08.gif"></p>     <p>&nbsp;</p>     <p><font size="2" face="Verdana"> After randomized cut-off to balance the sample    as to the risk factors that showed to be different in both groups of women (infected    and non-infected), which could make the results interpretation difficult for    developed countries, the statistical analysis continued showing that pregnancy    was the greatest risk factor, followed by low level of education, low income,    living previously in rural areas, lack of environmental sanitation, ingestion    of raw or underdone meat, ingestion of raw or underdone eggs, unpasteurized    goat's milk, and geophagia (<a href="#tab08">Table 8</a>). </font></p>     <p>&nbsp;</p>     <p><font size="3" face="Verdana"><B>Discussion</B> </font></p>     ]]></body>
<body><![CDATA[<p><font size="2" face="Verdana"> The prevalence of this infection varies in different    regions of the world and even of the same city, which could be observed in Goi&acirc;nia    during the period of this study &#91;28&#93;. The northwestern region of the city, where    the population has lower family income, had already shown a statistical risk    to acquire toxoplasmosis before the prevention program started. This city is    located in the Midwestern Region of Brazil and presents tropical  weather,    which favors the survival of <I>T. gondii</I> oocysts, a fact that increases    the chances of acquiring this infection when the women live in contaminated    environments. Furthermore, the high level of migratory flux favors the contamination    of women originally from other places presenting lower prevalence of the disease    &#91;1,2&#93;. The high percentage of women at childbearing age who are vulnerable to    this parasite (34.2%) favors primo-infection during pregnancy. </font></p>     <p><font size="2" face="Verdana"> This study demonstrated that women presenting    previous pregnancy have a 1.74 times higher risk of toxoplasmosis than non-previously    pregnant women (<a href="#tab01">Table 1</a>). This greater vulnerability of    pregnant women to the parasite is probably due to alterations in the immune    mechanisms inherent to gestation, resulting from supression of immune response    because of the necessity of tolerance to the graft (fetus) and/or as a consequence    of hormone imbalances characteristic of the gestational condition &#91;29&#93;.    </font></p>     <p><font size="2" face="Verdana"> This risky situation (pregnancy) adds to the    unfavorable conditions of life of the population that lives in underdeveloped    countries, increasing the chance of contamination of women, mainly during pregnancy,    when they become more vulnerable to the parasitic infection. </font></p>     <p><font size="2" face="Verdana"> Water contamination as a result of low level    of education increases the possibility of ingestion of contaminated food. In    fact, untreated water was consumed by 22.9% of the women; 40.2% of them lived    in houses lacking sewage system, and 7% lacking garbage collection. However,    comparing the group exposed to inadequate sanitary conditions with the presence    or absence of immunity to the protozoan, there were noticeable differences only    in women younger than 20 years in relation to untreated water and lack of sewage    treatment (<a href="#tab05">Table 5</a>). The lack of garbage collection represented    a higher risk, increasing in women at young age. This is in agreement with several    studies found in the literature, which indicate higher chances of contamination    when living in contact with such risk factors &#91;1,2,5&#93;. </font></p>     <p><font size="2" face="Verdana"> The presence of host animals (cats) in the house    was confirmed to be a risk for toxoplasmosis only when women reported previous    pregnancy, a fact not mentioned in the literature. This finding shows that the    simple fact of having animals at home is not enough to acquire the protozoan    infection, and that it is imperative to have contact with other infected sources    to be contaminated and present higher vulnerability to the invasor organism.    A multicenter case-control study carried out in Europe &#91;30&#93; did not identify    cats as a risk factor for seroconversion during pregnancy. </font></p>     <p><font size="2" face="Verdana"> The exposure to vehicles of oocyst transmission    was high in the studied population in general (<a href="#tab04">Table 4</a>).    However, this fact was statistically significant only when women reported previous    pregnancy (<a href="#tab04">Tables 4</a> and <a href="#tab05">5</a>). It was    also found in another study higher prevalence of seroconversion when there was    contact with rats, cats and coprophagous invertebrates &#91;10&#93;. </font></p>     <p><font size="2" face="Verdana"> In the present case, the findings are corroborated    by studies found in the literature &#91;1,2,4,5&#93; only for women that mentioned previous    pregnancy, probably due to physiological immunosuppression. </font></p>     <p><font size="2" face="Verdana"> The ingestion of raw or underdone meat was a    frequent habit in the analyzed population, as commented before (<a href="#tab06">Table    6</a>). However, there was no difference in exposure to this factor in both    groups (infected and non-infected), not showing to be a risk factor for the    studied population, except when the woman mentioned previous pregnancy. This    happening can be explained by the lower virulence of the <I>T. gondii</I> strain    that infects animals and also by the presence of some environmental factors    that increase the resistance of women to the parasite. </font></p>     <p><font size="2" face="Verdana"> The ingestion of raw or underdone inappropriately    washed vegetables was also a frequent habit among the studied population, corresponding    to 36.4% of the   women. The exposure was    similar for infected and non-infected women, though, differing only among the    women that mentioned prior pregnancy. </font></p>     <p><font size="2" face="Verdana"> The ingestion of unpasteurized goat's milk was    not usual, being observed in 12.8% of the population and the exposure to this    factor did not show statistical differences between the two groups of women.    </font></p>     ]]></body>
<body><![CDATA[<p><font size="2" face="Verdana"> Geophagia during childhood was not frequent    among the studied population, being referred by 21.3% of the women; it was not    found statistical difference as to this exposure for both groups of women. Geophagia    during pregnancy was reported by 38% of the studied women, but the two groups    showed no differences in exposure to this factor (<a href="#tab06">Table 6</a>),    a fact that was modified when the sample was balanced (<a href="#tab08">Table    8</a>). The present results, after balancing the sample, do not differ from    those found in the literature &#91;1,2,4&#93;, which mention geophagia as a    risk factor. </font></p>     <p><font size="2" face="Verdana"> It was not observed statistical significance    between soil handling in gardens and risk to acquire toxoplasmosis when the    women did not mention previous pregnancy. This can be explained by the adequate    defense of the woman's body, by the low significance of the inoculum amount    or by the lower aggressiveness of the existing <I>T. gondii</I> strain in the    soil, which would require a weak organism in order to cause infection. In case    of previous pregnancy, the contamination risk was higher in women younger than    20 years (<a href="#tab05">Tables 5</a> and <a href="#tab06">6</a>). </font></p>     <p><font size="2" face="Verdana"> Susceptible individuals submitted to contaminated    environments can be easily infected, as shown in this study. Pregnant women    present with higher probability of being contaminated, regardless their life    conditions. Finding this situation, the protozoan sources of infection present    greater importance, because the pregnant woman is more vulnerable and a lower    inoculum of the parasite or a less aggressive strain can infect her. </font></p>     <p><font size="2" face="Verdana"> There are controversial studies in the literature,    which evaluated the validity of the preventive program mainly in countries where    this infection is not highly frequent. The researches tend to analyze the operational    costs of the governmental programs and show divergent opinions concerning the    secondary prevention. The lower cost of primary prevention is not questioned,    because the investments are related to education and this is an obligation of    the State. However, when secondary prevention is mentioned, with identification    and follow-up of the women at risk, the cost-benefit analysis is imposed. </font></p>     <p><font size="2" face="Verdana"> The present study demonstrates a high vulnerability    of the pregnant women to the protozoan and suggests that the public health policy    should include primary and secondary prevention for all pregnant women at high    risk. The benefits resulting from lower incidence of congenital toxoplasmosis    with the adoption of these measures justify the costs, because it guarantees    good quality life to infected fetuses. The early identification of the fetus    infection and the introduction of immediate appropriate therapy open an opportunity    for the individuals to have better life expectation and a worthy future. </font></p>     <p><font size="2" face="Verdana"> In conclusion, previous pregnancy showed to    be the greatest risk factor to toxoplasmosis infection in the studied population.    This has already been confirmed in another study carried out for the seronegative    women found among the same population analyzed in the present study &#91;31&#93;. In    that research, the presence of gestation increased the risk to acquire toxoplasmosis,    being 2.2 times higher for pregnant women in general and 7.7 times higher for    pregnant adolescents. </font></p>     <p>&nbsp;</p>     <p><font size="3" face="Verdana"><B>Acknowledgements</B> </font></p>     <p><font size="2" face="Verdana"> The following institutions provide research    facilities and funding support for this research: Medical School, Federal University    of Goi&aacute;s (FM-UFG), Institute of Tropical Pathology and Public Health,    Federal University of Goi&aacute;s (IPTESP-UFG), National Foundation for the    Support of Research (FUNAPE), State and Municipal Secretaries of Health of the    State of Goi&aacute;s. </font></p>     <p>&nbsp;</p>     ]]></body>
<body><![CDATA[<p><font size="3" face="Verdana"><B>References</B> </font></p>     <!-- ref --><p><font size="2" face="Verdana"> 1. Boyer K.M., Remington J.S., MacLeod R.L.    Toxoplasmosis. In: Feigin, R.D., Cherry, J.D. eds. Textbook    of pediatric infectious diseases. Philadelphia: WB Saunders Company,    <B>1998</B>. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000114&pid=S1413-8670200400020000700001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana"> 2. Remington J.S., Desmonts G.. Toxoplasmosis.    In: Remington J.S., Klein, J.O. Infectious diseases of the fetus and newborn    infant. 3.ed. Philadelphia: W.B. Saunders Company, <B>1990</B>. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000115&pid=S1413-8670200400020000700002&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana"> 3. Couvier J., Desmonts G. Congenital and maternal    toxoplasmosis. A review of 300 cases. Dev Med Child Neurol <B>1962</B>; 4:519-530.    </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000116&pid=S1413-8670200400020000700003&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana"> 4. Frenkel J.K. Toxoplasmose. In: Veronesi,    R. Tratado de infectologia. 2. ed. S&atilde;o Paulo: Atheneu, <B>1996</B>. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000117&pid=S1413-8670200400020000700004&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana"> 5. Andrade G.M.Q., Tonelli E., Or&eacute;fice    F. Toxoplasmose. In: Tonelli, E., Freire, L.M.S. Doen&ccedil;as infecciosas    na inf&acirc;ncia e adolesc&ecirc;ncia. 2. ed. Rio de Janeiro: Medsi, <B>2000</B>.    </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000118&pid=S1413-8670200400020000700005&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana"> 6. Avelino M.M. Infec&ccedil;&otilde;es intra-uterinas    em rec&eacute;m-nascidos de uma maternidade de refer&ecirc;ncia de Goi&acirc;nia.    Disserta&ccedil;&atilde;o de Mestrado em Doen&ccedil;as Infecciosas e Parasit&aacute;rias,    Instituto de Patologia Tropical e Sa&uacute;de P&uacute;blica, Universidade    Federal de Goi&aacute;s, Goi&acirc;nia, <B>1990</B>. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000119&pid=S1413-8670200400020000700006&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana"> 7. Desmonts G., Couvreur J. Congenital toxoplasmosis.    A prospective study of 378 pregnancies. N Engl J Med <B>1974</B>;290:1110-6.    </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000120&pid=S1413-8670200400020000700007&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana"> 8. Kope J.G., Loewer-Sieger D.H. Results of    20-year follow-up of congenital toxoplasmosis. Lancet <B>1986</B>;1(8475):254-6.    </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000121&pid=S1413-8670200400020000700008&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana"> 9. Feldman H.A. Congenital toxoplasmosis: a    study of one hundred three cases. Am J Dis Child <B>1953</B>;86:487-9. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000122&pid=S1413-8670200400020000700009&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">10. Wallace G.D. Experimental transmission of    <I>Toxoplasma gondii</I> by cockroaches. J Infect Dis <B>1972</B>;126:545-7.    </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000123&pid=S1413-8670200400020000700010&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">11. Desmonts G., Hassanein R.S., Brow E., et    al. Transmission of <I>T. gondii</I> in Panama City, Panama: a five-year prospective    cohort study of children, cats, rodents, birds, and soil. Am J Trop Med    Hyg <B>1995</B>;53(5):458-68. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000124&pid=S1413-8670200400020000700011&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">12. Jacquier P., Hohfeld P., Vorkauf H., Zuber    P. Epidemiology of toxoplasmosis in Switzerland: national study of seroprevalence    monitored in pregnant women 1990-1991. Schweiz Med Wochenschr <B>1995</B>;(Suppl    65):29S-38S. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000125&pid=S1413-8670200400020000700012&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">13. Jaqueti J., Hernandez-Garcia R., Nicolas    D., et al. Serology against <I>T. gondii</I> in pregnant women. Development    of prevalence rates in course of 4 years. Rev Clin Esp <B>1991</B>;188(6):278-80.    </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000126&pid=S1413-8670200400020000700013&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">14. Ljungstrom I., Gille E., Nokes J., et al.    Seroepidemiology <I>of T. gondii</I> among pregnant women in different parts    of Sweden. Eur J Epidemiol <B>1995</B>;11(2):1449-56. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000127&pid=S1413-8670200400020000700014&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">15. Lappalainen M., Koskela P., Hedman K., et    al Incidence of primary toxoplasma infections during pregnancy in southern Finland:    a prospective cohort study. Scand J Infect Dis <B>1992</B>;24(1):97-104. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000128&pid=S1413-8670200400020000700015&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">16. Lebech M., Laresen S.O., Peterson E. Occurrence    of toxoplasmosis in pregnant women in Denmark. A study of 5,402 pregnant women.    Ugeskr Laeger <B>1995</B>;157(38):5242-5. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000129&pid=S1413-8670200400020000700016&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">17. Forsgren M., Gille E., Ljungstrom I. <I>T.    gondii</I> antibodies in pregnant women in Stockholm in 1969, 1979, and 1987.    Lancet <B>1991</B>;337(8):1413-4. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000130&pid=S1413-8670200400020000700017&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">18. Lebech M., Larsen S.O., Petersen F. Prevalence,    incidence and geographical distribuition of <I>Toxoplasma gondii</I> antibodies    in pregnant women in Denmark. Scand J Infect Dis <B>1993</B>;25(6):751-6. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000131&pid=S1413-8670200400020000700018&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">19. Stray-Pederson B., Lorentzen-Styr A.M. The    prevalence of toxoplasma antibodies among 11,736 pregnany women in Norway. Scand    J Infect Dis <B>1979</B>;11:159-65. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000132&pid=S1413-8670200400020000700019&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">20. Logar J., Novak-Antolic Z., Zore A., et al.    Incidence of congenital toxoplasmosis in the Republic of Slovenia. Scand J Infect    Dis <B>1992</B>;24(1):105-8. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000133&pid=S1413-8670200400020000700020&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">21. Walpole I.R., Hodgen N., Bower C. Congenital    toxoplasmosis: a large survey in Western Australia. Med J Aust <B>1991</B>;154:720-4.    </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000134&pid=S1413-8670200400020000700021&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">22. Conyn-van Spaendonck M.A.E., Knapen van F.    Choices in preventive strategies: experience with the prevention of congenital    toxoplasmosis in the Netherlands. Scand J Infect Dis <B>1992</B>;84(Suppl):    51-8. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000135&pid=S1413-8670200400020000700022&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">23. Falkoff R. Maternal immunologic changes during    pregnancy: A critical appraisal.Clin Rev Allergy <B>1987</B>;5:287-300. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000136&pid=S1413-8670200400020000700023&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">24. Feinberg B.B., Gonik B. General precepts    of the immunology of pregnancy. Clin Obstet Gynecol <B>1991</B>;34:3-16. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000137&pid=S1413-8670200400020000700024&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">25. Gotlieb W.H. Immunology of pregnancy. Rev    Med Brux <B>1992</B>;13(4):97-101. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000138&pid=S1413-8670200400020000700025&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">26. Klink M., Rozalska B., Rudnicka W. Feto-maternal    immunoregulation. Postepy Hig Med Dosw <B>1994</B>;48(5):543-63. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000139&pid=S1413-8670200400020000700026&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">27. Crouch S.P.M., Crocker I.O., Fletcher, J.    The effect of pregnancy on polymorphonuclear leukocyte function. J Immunology    <B>1995</B>;155(11):5436-43. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000140&pid=S1413-8670200400020000700027&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">28. Avelino M.M., Campos Jr. D., Parada J.C.B.,    Castro A.M. Distribui&ccedil;&atilde;o sociogeogr&aacute;fica da toxoplasmose    em Goi&acirc;nia. Rev Bras Ginecol Obstetr <B>1999</B>;1(Suppl):72. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000141&pid=S1413-8670200400020000700028&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">29. Daunter B. Immunology of pregnancy: towards    a unifying hypothesis. Eur J Obstet Gynecol Reprod Biol <B>1992</B>;43:81-95.    </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000142&pid=S1413-8670200400020000700029&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">30. Cook A.J.C., Gilbert R.E., Buffolano W.,    et al. Sources of toxoplasma infection in pregnant women: European multicentre    case-control study. BJM <B>2000</B>;321:142-7. </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000143&pid=S1413-8670200400020000700030&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font size="2" face="Verdana">31. Avelino M. M., Campos Jr. D., Parada J.C.B.    de, Castro A.M. Pregnancy as a risk factor for acute toxoplasmosis seroconversion.    Eur J Obstet Gynecol Reprod Biol <B>2003</B>;108:19-24.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000144&pid=S1413-8670200400020000700031&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p>&nbsp;</p>     <p>&nbsp;</p>     <p><font size="2" face="Verdana"><a name="end"></a><a href="#tx"><img src="/img/revistas/bjid/v8n2/seta.gif" border="0"></a>    <b>Correspondence to</b>    <br>   Dr. Mariza Martins Avelino    <br>   Rua 135, nº 100, BL. C, apto. 102, Ed. Morada do Bosque, Setor Marista    <br>   Zip code: 74180-020. Goi&acirc;nia-GO, Brazil    <br>   Phone: 021(62)2412937; Fax: 021(62)2151838    <br>   E-mail: <a href="mailto:bmb@terra.com.br">bmb@terra.com.br</a></font></p>     ]]></body>
<body><![CDATA[<p><font size="2" face="Verdana">Received on 17 November 2003; revised 15 March    2004. </font></p>      ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Boyer]]></surname>
<given-names><![CDATA[K.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Remington]]></surname>
<given-names><![CDATA[J.S.]]></given-names>
</name>
<name>
<surname><![CDATA[MacLeod]]></surname>
<given-names><![CDATA[R.L.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Toxoplasmosis]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Feigin]]></surname>
<given-names><![CDATA[R.D.]]></given-names>
</name>
<name>
<surname><![CDATA[Cherry]]></surname>
<given-names><![CDATA[J.D.]]></given-names>
</name>
</person-group>
<source><![CDATA[Textbook of pediatric infectious diseases]]></source>
<year>1998</year>
<publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[WB Saunders Company]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Remington]]></surname>
<given-names><![CDATA[J.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Desmonts]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Toxoplasmosis]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Remington]]></surname>
<given-names><![CDATA[J.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Klein]]></surname>
<given-names><![CDATA[J.O.]]></given-names>
</name>
</person-group>
<source><![CDATA[Infectious diseases of the fetus and newborn infant]]></source>
<year>1990</year>
<edition>3</edition>
<publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[W.B. Saunders Company]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Couvier]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Desmonts]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Congenital and maternal toxoplasmosis: A review of 300 cases]]></article-title>
<source><![CDATA[Dev Med Child Neurol]]></source>
<year>1962</year>
<volume>4</volume>
<page-range>519-530</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Frenkel]]></surname>
<given-names><![CDATA[J.K.]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Toxoplasmose]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Veronesi]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Tratado de infectologia]]></source>
<year>1996</year>
<edition>2</edition>
<publisher-loc><![CDATA[São Paulo ]]></publisher-loc>
<publisher-name><![CDATA[Atheneu]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Andrade]]></surname>
<given-names><![CDATA[G.M.Q.]]></given-names>
</name>
<name>
<surname><![CDATA[Tonelli]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Oréfice]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Toxoplasmose]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Tonelli]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Freire]]></surname>
<given-names><![CDATA[L.M.S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Doenças infecciosas na infância e adolescência]]></source>
<year>2000</year>
<edition>2</edition>
<publisher-loc><![CDATA[Rio de Janeiro ]]></publisher-loc>
<publisher-name><![CDATA[Medsi]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Avelino]]></surname>
<given-names><![CDATA[M.M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Infecções intra-uterinas em recém-nascidos de uma maternidade de referência de Goiânia]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Desmonts]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Couvreur]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Congenital toxoplasmosis: A prospective study of 378 pregnancies]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>1974</year>
<volume>290</volume>
<page-range>1110-6</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kope]]></surname>
<given-names><![CDATA[J.G.]]></given-names>
</name>
<name>
<surname><![CDATA[Loewer-Sieger]]></surname>
<given-names><![CDATA[D.H.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Results of 20-year follow-up of congenital toxoplasmosis]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>1986</year>
<volume>1</volume>
<numero>8475</numero>
<issue>8475</issue>
<page-range>254-6</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Feldman]]></surname>
<given-names><![CDATA[H.A.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Congenital toxoplasmosis: a study of one hundred three cases]]></article-title>
<source><![CDATA[Am J Dis Child]]></source>
<year>1953</year>
<volume>86</volume>
<page-range>487-9</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wallace]]></surname>
<given-names><![CDATA[G.D.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Experimental transmission of Toxoplasma gondii by cockroaches]]></article-title>
<source><![CDATA[J Infect Dis]]></source>
<year>1972</year>
<volume>126</volume>
<page-range>545-7</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Desmonts]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Hassanein]]></surname>
<given-names><![CDATA[R.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Brow]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Transmission of T. gondii in Panama City, Panama: a five-year prospective cohort study of children, cats, rodents, birds, and soil]]></article-title>
<source><![CDATA[Am J Trop Med Hyg]]></source>
<year>1995</year>
<volume>53</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>458-68</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jacquier]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Hohfeld]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Vorkauf]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Zuber]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Epidemiology of toxoplasmosis in Switzerland: national study of seroprevalence monitored in pregnant women 1990-1991]]></article-title>
<source><![CDATA[Schweiz Med Wochenschr]]></source>
<year>1995</year>
<numero>^s65</numero>
<issue>^s65</issue>
<supplement>65</supplement>
<page-range>29S-38S</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jaqueti]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Hernandez-Garcia]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Nicolas]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Serology against T. gondii in pregnant women]]></article-title>
<source><![CDATA[Development of prevalence rates in course of 4 years. Rev Clin Esp]]></source>
<year>1991</year>
<volume>188</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>278-80</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ljungstrom]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Gille]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Nokes]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Seroepidemiology of T gondii among pregnant women in different parts of Sweden]]></article-title>
<source><![CDATA[Eur J Epidemiol]]></source>
<year>1995</year>
<volume>11</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>1449-56</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lappalainen]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Koskela]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Hedman]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Incidence of primary toxoplasma infections during pregnancy in southern Finland: a prospective cohort study]]></article-title>
<source><![CDATA[Scand J Infect Dis]]></source>
<year>1992</year>
<volume>24</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>97-104</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lebech]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Laresen]]></surname>
<given-names><![CDATA[S.O.]]></given-names>
</name>
<name>
<surname><![CDATA[Peterson]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Occurrence of toxoplasmosis in pregnant women in Denmark: A study of 5,402 pregnant women]]></article-title>
<source><![CDATA[Ugeskr Laeger]]></source>
<year>1995</year>
<volume>157</volume>
<numero>38</numero>
<issue>38</issue>
<page-range>5242-5</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Forsgren]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Gille]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Ljungstrom]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[T. gondii antibodies in pregnant women in Stockholm in 1969, 1979, and 1987]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>1991</year>
<volume>337</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1413-4</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lebech]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Larsen]]></surname>
<given-names><![CDATA[S.O.]]></given-names>
</name>
<name>
<surname><![CDATA[Petersen]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Prevalence, incidence and geographical distribuition of Toxoplasma gondii antibodies in pregnant women in Denmark]]></article-title>
<source><![CDATA[Scand J Infect Dis]]></source>
<year>1993</year>
<volume>25</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>751-6</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stray-Pederson]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Lorentzen-Styr]]></surname>
<given-names><![CDATA[A.M.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The prevalence of toxoplasma antibodies among 11,736 pregnany women in Norway]]></article-title>
<source><![CDATA[Scand J Infect Dis]]></source>
<year>1979</year>
<volume>11</volume>
<page-range>159-65</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Logar]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Novak-Antolic]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Zore]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Incidence of congenital toxoplasmosis in the Republic of Slovenia]]></article-title>
<source><![CDATA[Scand J Infect Dis]]></source>
<year>1992</year>
<volume>24</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>105-8</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Walpole]]></surname>
<given-names><![CDATA[I.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Hodgen]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Bower]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Congenital toxoplasmosis: a large survey in Western Australia]]></article-title>
<source><![CDATA[Med J Aust]]></source>
<year>1991</year>
<volume>154</volume>
<page-range>720-4</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Conyn-van Spaendonck]]></surname>
<given-names><![CDATA[M.A.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Knapen]]></surname>
<given-names><![CDATA[van F.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Choices in preventive strategies: experience with the prevention of congenital toxoplasmosis in the Netherlands]]></article-title>
<source><![CDATA[Scand J Infect Dis]]></source>
<year>1992</year>
<volume>84</volume>
<numero>^sSuppl</numero>
<issue>^sSuppl</issue>
<supplement>Suppl</supplement>
<page-range>51-8</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Falkoff]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Maternal immunologic changes during pregnancy: A critical appraisal]]></article-title>
<source><![CDATA[Clin Rev Allergy]]></source>
<year>1987</year>
<volume>5</volume>
<page-range>287-300</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Feinberg]]></surname>
<given-names><![CDATA[B.B.]]></given-names>
</name>
<name>
<surname><![CDATA[Gonik]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[General precepts of the immunology of pregnancy]]></article-title>
<source><![CDATA[Clin Obstet Gynecol]]></source>
<year>1991</year>
<volume>34</volume>
<page-range>3-16</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gotlieb]]></surname>
<given-names><![CDATA[W.H.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Immunology of pregnancy]]></article-title>
<source><![CDATA[Rev Med Brux]]></source>
<year>1992</year>
<volume>13</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>97-101</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Klink]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Rozalska]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Rudnicka]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Feto-maternal immunoregulation]]></article-title>
<source><![CDATA[Postepy Hig Med Dosw]]></source>
<year>1994</year>
<volume>48</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>543-63</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Crouch]]></surname>
<given-names><![CDATA[S.P.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Crocker]]></surname>
<given-names><![CDATA[I.O.]]></given-names>
</name>
<name>
<surname><![CDATA[Fletcher,]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The effect of pregnancy on polymorphonuclear leukocyte function]]></article-title>
<source><![CDATA[J Immunology]]></source>
<year>1995</year>
<volume>155</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>5436-43</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Avelino]]></surname>
<given-names><![CDATA[M.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Campos]]></surname>
<given-names><![CDATA[Jr. D.]]></given-names>
</name>
<name>
<surname><![CDATA[Parada]]></surname>
<given-names><![CDATA[J.C.B.]]></given-names>
</name>
<name>
<surname><![CDATA[Castro]]></surname>
<given-names><![CDATA[A.M.]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Distribuição sociogeográfica da toxoplasmose em Goiânia]]></article-title>
<source><![CDATA[Rev Bras Ginecol Obstetr]]></source>
<year>1999</year>
<volume>1</volume>
<numero>Suppl</numero>
<issue>Suppl</issue>
<page-range>72</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Daunter]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Immunology of pregnancy: towards a unifying hypothesis]]></article-title>
<source><![CDATA[Eur J Obstet Gynecol Reprod Biol]]></source>
<year>1992</year>
<volume>43</volume>
<page-range>81-95</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cook]]></surname>
<given-names><![CDATA[A.J.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Gilbert]]></surname>
<given-names><![CDATA[R.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Buffolano]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Sources of toxoplasma infection in pregnant women: European multicentre case-control study]]></article-title>
<source><![CDATA[BJM]]></source>
<year>2000</year>
<volume>321</volume>
<page-range>142-7</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Avelino]]></surname>
<given-names><![CDATA[M. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Campos]]></surname>
<given-names><![CDATA[Jr. D.]]></given-names>
</name>
<name>
<surname><![CDATA[Parada]]></surname>
<given-names><![CDATA[J.C.B. de]]></given-names>
</name>
<name>
<surname><![CDATA[Castro]]></surname>
<given-names><![CDATA[A.M.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Pregnancy as a risk factor for acute toxoplasmosis seroconversion]]></article-title>
<source><![CDATA[Eur J Obstet Gynecol Reprod Biol]]></source>
<year>2003</year>
<volume>108</volume>
<page-range>19-24</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
